ICON PLC (ICLR) - Total Assets

Latest as of June 2026: $16.40 Billion USD

Based on the latest financial reports, ICON PLC (ICLR) holds total assets worth $16.40 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

ICON PLC - Total Assets Trend (1998–2025)

This chart illustrates how ICON PLC's total assets have evolved over time, based on quarterly financial data. Also see ICON PLC market cap and net worth for the company's overall valuation and market capitalisation.

ICON PLC - Asset Composition Analysis

Current Asset Composition (December 2025)

ICON PLC's total assets of $16.40 Billion consist of 21.5% current assets and 78.5% non-current assets. Review how much debt does ICON PLC carry to assess the company's total debt and financial obligations.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.0%
Accounts Receivable $2.75 Billion 16.9%
Inventory $0.00 0.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $3.25 Billion 20.0%
Goodwill $8.73 Billion 53.7%

Asset Composition Trend (1998–2025)

This chart illustrates how ICON PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for ICON PLC for real-time trading data and today's change.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: ICON PLC's current assets represent 21.5% of total assets in 2025, a decrease from 83.4% in 1998.
  • Cash Position: Cash and equivalents constituted 4.0% of total assets in 2025, down from 12.8% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 72.0% of total assets, an increase from 0.0% in 1998.
  • Asset Diversification: The largest asset category is goodwill at 53.7% of total assets.

ICON PLC Competitors by Total Assets

Key competitors of ICON PLC based on total assets are shown below.

Company Country Total Assets
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩335.22 Billion
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million
Scope Fluidics SA
WAR:SCP
Poland zł141.67 Million
Eurofins-Cerep SA
PA:ALECR
France €88.84 Million
Check-Cap Ltd
F:7CC
Germany €7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million

ICON PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.95 1.29 1.36
Quick Ratio 0.95 1.29 1.36
Cash Ratio 0.00 0.00 0.00
Working Capital $-186.02 Million $752.44 Million $828.45 Million

ICON PLC - Advanced Valuation Insights

This section examines the relationship between ICON PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.37
Latest Market Cap to Assets Ratio 0.79
Asset Growth Rate (YoY) -3.6%
Total Assets $16.27 Billion
Market Capitalization $12.90 Billion USD

Valuation Analysis

Below Book Valuation: The market values ICON PLC's assets below their book value (0.79x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: ICON PLC's assets decreased by 3.6% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for ICON PLC (1998–2025)

The table below shows the annual total assets of ICON PLC from 1998 to 2025.

Year Total Assets Change
2025-12-31 $16.27 Billion -3.60%
2024-12-31 $16.88 Billion -0.66%
2023-12-31 $16.99 Billion -1.14%
2022-12-31 $17.19 Billion -1.16%
2021-12-31 $17.39 Billion +406.09%
2020-12-31 $3.44 Billion +18.16%
2019-12-31 $2.91 Billion +21.84%
2018-12-31 $2.39 Billion +9.17%
2017-12-31 $2.19 Billion +19.72%
2016-12-31 $1.83 Billion +6.22%
2015-12-31 $1.72 Billion +12.51%
2014-12-31 $1.53 Billion +5.92%
2013-12-31 $1.44 Billion +19.99%
2012-12-31 $1.20 Billion +16.09%
2011-12-31 $1.04 Billion +9.05%
2010-12-31 $949.54 Million +4.53%
2009-12-31 $908.40 Million +4.74%
2008-12-31 $867.28 Million +25.12%
2007-12-31 $693.14 Million +45.51%
2006-12-31 $476.34 Million +36.46%
2005-12-31 $349.07 Million +4.10%
2004-12-31 $335.32 Million +79.39%
2003-12-31 $186.92 Million -20.46%
2002-12-31 $235.01 Million +58.45%
2001-12-31 $148.32 Million +33.78%
2000-12-31 $110.87 Million +10.74%
1999-12-31 $100.12 Million +6.74%
1998-12-31 $93.80 Million --

About ICON PLC

NASDAQ:ICLR USA Diagnostics & Research
Market Cap
$13.31 Billion
Market Cap Rank
#1826 Global
#694 in USA
Share Price
$172.45
Change (1 day)
+2.08%
52-Week Range
$80.08 - $202.92
All Time High
$346.20
About

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It… Read more